Phase 1B of TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC

Conditions: Squamous Cell Carcinoma of Head and Neck; Metastatic Squamous Cell Carcinoma Interventions: Biological: TBio-4101; Drug: Pembrolizumab; Drug: Platinum based chemotherapy; Drug: Cyclophosphamide; Drug: Fludarabine; Drug: Aldesleukin Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Turnstone Biologics, Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials